DENTSPLY SIRONA INC.

(XRAY)
  Report
Delayed Nasdaq  -  04:00 2022-08-17 pm EDT
35.75 USD   -2.80%
04:02pModerna Discloses New CFO Mock's Pay
DJ
08:52aModerna, PerkinElmer Name New Financial Chiefs
DJ
08/15DENTSPLY SIRONA INC. : Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/11/2022 08/12/2022 08/15/2022 08/16/2022 08/17/2022 Date
37.17(c) 37.65(c) 37.6(c) 36.78(c) 35.75 Last
1 455 386 982 741 1 144 926 2 362 849 2 193 656 Volume
+0.35% +1.29% -0.13% -2.18% -2.80% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 4 123 M - -
Net income 2022 336 M - -
Net Debt 2022 1 479 M - -
P/E ratio 2022 23,1x
Yield 2022 1,24%
Sales 2023 4 261 M - -
Net income 2023 379 M - -
Net Debt 2023 1 182 M - -
P/E ratio 2023 20,2x
Yield 2023 1,29%
Capitalization 7 702 M 7 702 M -
EV / Sales 2022 2,23x
EV / Sales 2023 2,09x
Nbr of Employees 15 000
Free-Float 99,6%
More Financials
Company
DENTSPLY SIRONA Inc. is the world's leader in design, manufacturing and marketing of dental care and oral hygiene products and equipment. Net sales break down by family of products as follows: - specialized products and equipment (59.4%): CAD / CAM systems, dental treatment centers, imaging systems, panoramic and 3D imaging systems, implants, orthodontics products and accessories, etc.; - consumables (40.6%): food... 
More about the company
Ratings of DENTSPLY SIRONA Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about DENTSPLY SIRONA INC.
04:02pModerna Discloses New CFO Mock's Pay
DJ
08:52aModerna, PerkinElmer Name New Financial Chiefs
DJ
08/15DENTSPLY SIRONA INC. : Entry into a Material Definitive Agreement, Notice of Delisting or ..
AQ
08/15Dentsply Sirona Receives Notice of Filing Delinquency from Nasdaq
AQ
08/09DENTSPLY SIRONA INC. : Change in Directors or Principal Officers (form 8-K)
AQ
08/09DENTSPLY SIRONA Inc. Announces Executive Changes
CI
08/05Dentsply Sirona Issues Q2 Projections; Submits New Compliance Plan to Nasdaq as Investi..
MT
08/05William Blair Downgrades Dentsply Sirona to Underperform From Market Perform
MT
08/04Dentsply Sirona Provides Business Update
AQ
08/04Dentsply Sirona Inc. Declares Quarterly Cash Dividend, Payable on October 14, 2022
CI
08/04Dentsply Sirona Inc. Provides Earnings Guidance for Second Quarter 2022
CI
07/29DENTSPLY 72 HOUR DEADLINE ALERT : Former Louisiana Attorney General and Kahn Swick & Foti,..
BU
07/21Goldman Sachs Trims Price Target on Dentsply Sirona to $41 From $42, Maintains Neutral ..
MT
07/20Morgan Stanley Adjusts Price Target on Dentsply Sirona to $44 From $48, Maintains Overw..
MT
07/14Interim report for Q2 2022
AQ
More news
News in other languages on DENTSPLY SIRONA INC.
08/09DENTSPLY SIRONA Inc. annonce des changements de direction
08/05Dentsply Sirona publie ses prévisions pour le 2e trimestre ; soumet un nouveau plan de ..
08/04Dentsply Sirona Inc. Fournit des prévisions de résultats pour le deuxième trimestre 202..
08/04Dentsply Sirona Inc. Déclare un dividende trimestriel en espèces, payable le 14 octobre..
05/27Dentsply Sirona déclare un dividende trimestriel en espèces, payable le 8 juillet 2022
More news
Analyst Recommendations on DENTSPLY SIRONA INC.
More recommendations
Chart DENTSPLY SIRONA INC.
Duration : Period :
DENTSPLY SIRONA Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DENTSPLY SIRONA INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 35,75 $
Average target price 42,45 $
Spread / Average Target 18,8%
EPS Revisions
Managers and Directors
John P. Groetelaars Chief Executive Officer & Independent Director
Barbara W. Bodem Chief Financial & Accounting Officer
Eric K. Brandt Non-Executive Chairman
Cord F. Stähler Chief Technology Officer & Senior Vice President
Harry M. Jansen Kraemer Independent Director
Sector and Competitors
1st jan.Capi. (M$)
DENTSPLY SIRONA INC.-34.07%7 924
ABBOTT LABORATORIES-20.40%196 189
MEDTRONIC PLC-7.87%126 639
BECTON, DICKINSON AND COMPANY8.96%76 370
HOYA CORPORATION-12.97%39 454
SARTORIUS STEDIM BIOTECH-18.97%36 666